<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Bioinformatics</title>
<link>http://depot.umc.edu.dz/handle/123456789/14447</link>
<description/>
<pubDate>Tue, 02 Jun 2026 03:07:48 GMT</pubDate>
<dc:date>2026-06-02T03:07:48Z</dc:date>
<item>
<title>BP-09: Decoding the Genome: Advancing Anomaly Detection through Machine  Learning</title>
<link>http://depot.umc.edu.dz/handle/123456789/14711</link>
<description>BP-09: Decoding the Genome: Advancing Anomaly Detection through Machine  Learning
ALIOUANE, Salah Eddine; CHEHILI, Hamza; BOULAHROUF, Khaled; ABDELAZIZ, Aya; HAMIDECHI, Mohamed Abdelhafid
This presentation explores the fusion of genomic analysis and machine &#13;
learning with the aim of revolutionizing anomaly detection in genetics. This advancement is seen as &#13;
propelling precision medicine and enhancing advanced diagnostics. &#13;
Objectives: The objectives include the investigation of the application of machine learning in &#13;
the detection of genetic anomalies. This aims to elucidate its potential in early disease identification &#13;
and the provision of personalized healthcare. &#13;
Methods: The presentation begins with an introduction to genomics, highlighting the necessity &#13;
of artificial intelligence in dealing with the vast amount of genomic big data. It then proceeds to delve &#13;
into various machine learning tools, such as DeepVariant, VarSome Clinical, and Deep SEA. &#13;
Throughout this exploration, the presentation unveils the data sources, predictive capabilities, and the &#13;
profound impact these tools have on the interpretation of genomics. &#13;
Results and discussion: During this segment, it is demonstrated that by harnessing the prowess &#13;
of artificial intelligence, enhanced accuracy in the identification of genetic anomalies can be &#13;
showcased. This results in the faster analysis of vast genomic datasets, opening the door to potential &#13;
groundbreaking biomedical discoveries. &#13;
Conclusion: In conclusion, the amalgamation of genomics and machine learning heralds a &#13;
paradigm shift in the domains of disease detection and treatment, ushering in a new era characterized &#13;
by tailored healthcare
</description>
<pubDate>Thu, 05 Oct 2023 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://depot.umc.edu.dz/handle/123456789/14711</guid>
<dc:date>2023-10-05T00:00:00Z</dc:date>
</item>
<item>
<title>BP-08: Exploring the Impact of Some Parameters and Their Interactions on the  MAFFT MSA Tool Using the Design of Experiments</title>
<link>http://depot.umc.edu.dz/handle/123456789/14710</link>
<description>BP-08: Exploring the Impact of Some Parameters and Their Interactions on the  MAFFT MSA Tool Using the Design of Experiments
ROUABAH, Safia; DAAS, Skander; BOULAHROUF, Khaled; HAMIDECHI, Mohamed Abdelhafid
Multiple Sequence Alignment (MSA) is essential in bioinformatics for identifying conserved &#13;
regions and evolutionary relationships among biological sequences. Due to its efficiency and precision, &#13;
the MAFFT algorithm is a popular tool for conducting MSA. However, the effect of numerous &#13;
parameters and their interactions on some performance metrics remains relatively underexplored. &#13;
 &#13;
In this study, we investigate the effects and interactions of four important parameters: number of &#13;
sequences, sequence length, insertion rate, and deletion rate, on four performance metrics of the &#13;
MAFFT tool. &#13;
 &#13;
By generating a diverse dataset of biological sequences, we carried out a comprehensive &#13;
analysis of MAFFT's performance in terms of Sum of Pairs Score (SPS), Column Score (CS), and &#13;
Delay. Through a series of controlled experiments using the design of experiments, we assessed the &#13;
impact of parameters’ variation and their interactions on these performance metrics. &#13;
 &#13;
Our findings indicate that the considered parameters and their interactions significantly &#13;
influence the MAFFT’s performance across all the metrics. Specifically, the most influential &#13;
parameter in terms of SPS and CS quality is the number of sequences. However, the sequence length &#13;
parameter has a greater impact on the delay metric. Additionally, insertion and deletion rates, has a &#13;
relatively lower impact on all alignment quality metrics. &#13;
 &#13;
These results emphasize the importance of parameter impact and their interactions on the &#13;
MAFFT tool. The study provides insights into the interplay between MAFFT's parameter settings and &#13;
its performance, enabling researchers and practitioners to make informed decisions when applying &#13;
the tool to biological sequence alignment tasks.
</description>
<pubDate>Thu, 05 Oct 2023 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://depot.umc.edu.dz/handle/123456789/14710</guid>
<dc:date>2023-10-05T00:00:00Z</dc:date>
</item>
<item>
<title>BP-07: The application of machine learning techniques in rare diseases</title>
<link>http://depot.umc.edu.dz/handle/123456789/14709</link>
<description>BP-07: The application of machine learning techniques in rare diseases
NAIR, Safa; BOUCHEHAM, Anouar; CHEHILI, Hamza
Emerging machine learning (ML) techniques have the potential to &#13;
greatly improve rare disease (RDs) research and treatment. The use of artificial intelligence (AI) &#13;
technologies can be especially advantageous for the study of RDs, which are a diverse group of diseases &#13;
that impact a small percentage of the whole population and significantly underrepresented in basic and &#13;
clinical research. The difficulties faced by RDs (such as small patient population, geographical &#13;
dispersion, low diagnostic rates, etc.) can be overcome by using ML techniques. &#13;
Objectives: This review aims to highlight the accomplishments of AI algorithms in the study &#13;
of rare diseases and to guide researchers on which strategies have proven to be the most beneficial. &#13;
Methods: The study will focus on a few rare diseases. The Orphanet categorization was used, &#13;
and only RDs with Orpha codes were considered. And will look at which AI methodologies have been &#13;
most successful in their research. &#13;
Results and discussion: ML techniques demonstrate that no single strategy excels &#13;
universally; success is dependent on unique tasks and resources. The complexity, interpretability, and &#13;
data requirements of models differ. While deep learning can capture complicated patterns, it may be &#13;
difficult to interpret, as opposed to simpler models such as logistic regression. There is a clear trade&#13;
off between model complexity and performance. Ensemble learning, like random forests, is resistant &#13;
to noisy data. Deep learning necessitates enormous computational resources. Tuning hyperparameters &#13;
is crucial, and technique selection should be guided by domain-specific factors. &#13;
Conclusion: In conclusion, from the standpoint of precision medicine, AI algorithms can help &#13;
to design individualized treatment plans by finding biomarkers linked with a specific rare disease. AI &#13;
systems that discover, forecast, and classify mutations can advance RDs diagnosis, raising these figures &#13;
and uncovering new disease causes and therapeutic targets. &#13;
The AI-mediated knowledge of RDs could considerably accelerate therapeutic development
</description>
<pubDate>Thu, 05 Oct 2023 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://depot.umc.edu.dz/handle/123456789/14709</guid>
<dc:date>2023-10-05T00:00:00Z</dc:date>
</item>
<item>
<title>BP-06: Metagenomics: A strategy to study complex microbiota</title>
<link>http://depot.umc.edu.dz/handle/123456789/14708</link>
<description>BP-06: Metagenomics: A strategy to study complex microbiota
FERHAOUI, Nerdjes; SEBAIHIA, Mohammed
The development of genome-sequencing technologies, especially the application of next- &#13;
generation sequencing (NGS), has accelerated the study of complex microbiota. &#13;
Metagenomics plays a crucial role in expanding our knowledge of the microbial world, has &#13;
numerous applications across various fields, and holds the potential to address pressing global &#13;
challenges in health, the environment, and biotechnology. &#13;
This new approach has the potential to uncover novel enzymes, pathways, and molecules with &#13;
industrial applications. Furthermore, by analyzing metagenomic data, researchers can identify new &#13;
natural products with therapeutic potential. Many antibiotics, antivirals, and other pharmaceuticals &#13;
have been discovered through metagenomic approaches. &#13;
This work is intended to introduce different research methods to study complex microbiota, with &#13;
a specific focus on the current progress and application of metagenomics. &#13;
We discuss here computer programs used in metagenomics such as MEGAN, Kraken and MePIC &#13;
that allow analysis of large data sets by a single scientist. &#13;
We also highlight the necessity to begin studying complex infections using metagenomics &#13;
approach, which is essential for better understand the host–bacterial interactions
</description>
<pubDate>Thu, 05 Oct 2023 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://depot.umc.edu.dz/handle/123456789/14708</guid>
<dc:date>2023-10-05T00:00:00Z</dc:date>
</item>
</channel>
</rss>
